We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Direct Mailing Improves Screening for Colorectal Cancer

By LabMedica International staff writers
Posted on 26 Sep 2012
Print article
Direct mailing of fecal occult blood test (FOBT) kits to patients eligible for colorectal cancer screening appears to be efficacious for improving screening.

Appropriate screening and early detection can greatly reduce colorectal cancer, associated morbidity and mortality, and several national guidelines recommend regular screening for colorectal cancer among adults aged 50 years and older with high-sensitivity FOBT, sigmoidoscopy, or colonoscopy.

Scientists at Northwestern University (Chicago, IL, USA) conducted an outreach intervention program especially designed to patients who were overdue for colorectal cancer screening and were receiving care at a community health center that serves a primarily low-income population with a high proportion of immigrants and refugees. The patients were sent an FOBT kit with instructions on how to use it.

A total of 317 patients aged 50 to 80 years had at least two visits to the study site between July 1, 2008, and December 31, 2009, and were eligible for the colorectal cancer screening measure. In all, 98 patients were randomized to the usual care group and 104 were randomized to the outreach intervention. The patients were racially and ethnically diverse, more than one-half of patients were women, and the vast majority was uninsured or publicly insured.

The main outcome of the study was 30% of patients assigned to the outreach intervention and 5% of patients assigned to the usual care group completed colorectal cancer screening between January 1, 2010, and June 30, 2010. Almost all of the completed colorectal cancer screening tests were the three-sample guaiac-based FOBT, the Hemoccult II SENSA Elite kits (Beckman Coulter, Brea, CA, USA).

The authors concluded that the direct-to-patient outreach intervention was effective even in a health care setting that had already implemented point-of-care clinician-directed electronic clinical reminders to promote appropriate colorectal cancer screening. This finding is especially important given the marked disparities in colorectal screening among racial and ethnic minorities, individuals with lower income and educational attainment, the uninsured, and individuals born outside the USA. The study was published in the September/October 2012 issue of the Annals of Family Medicine.

Related Links:

Northwestern University

Beckman Coulter



Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Centrifuge
Centrifuge 5430/ 5430 R

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.